View in EDS HTML Full Text PDF Full Text

Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders.

Saved in:
Bibliographic Details
Title: Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders.
Authors: Wedemeyer H; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, OE6810, Carl-Neuberg-Str. 1, 30625 Hannover, Germany., Di Marco V; University of Palermo, Piazza Marina, 61, 90133 Palermo, Italy., Garcia-Retortillo M; Liver Section, Gastroenterology Department, Hospital del Mar-Parc de Salut Mar, Hospital del Mar Medical Research Institute (IMIM), C/ del Dr. Aiguader, 88, 08003 Barcelona, Spain., Teti E; Tor Vergata University, Via Cracovia, 50, 00133 Rome, Italy., Fraser C; Cool Aid Community Health Centre, 713 Johnson St, Victoria, BC V8W 1M8, Canada., Morano Amado LE; Unit of Infectious Diseases, Álvaro Cunqueiro University Hospital, Estrada de Clara Campoamor, 341, 36312 Vigo, Spain., Rodriguez-Tajes S; Liver Unit, Hospital Clinic Barcelona, IDIBAPS, CIBERehd, C. de Villarroel, 170, 08036 Barcelona, Spain., Acosta-López S; Digestive Diseases, Hospital Nuestra Señora de Candelaria, Ctra. Gral. del Rosario, 145, 38010 Tenerife, Spain., O'Loan J; Medeco Inala & Kombi Clinic, 55b/156 Inala Ave, Brisbane, QLD 4077, Australia.; School of Medicine, University of Queensland, St Lucia, Brisbane, QLD 4072, Australia., Milella M; Clinic of Infectious Diseases, University of Bari, Piazza Umberto I, 1, 70121 Bari, Italy., Buti M; Liver Unit, Vall d'Hebron University Hospital, and CIBEREHD del Instituto Carlos III, Barcelona, Spain., Guerra-Veloz MF; Virgen Macarena University Hospital, Av. Dr. Fedriani, 3, 41003 Seville, Spain.; Clinical Research Fellow in Hepatology at King's College Hospital, Denmark Hill, London SE5 9RS, UK., Ramji A; University of British Columbia, Vancouver, BC V6T 1Z4, Canada., Fenech M; Queensland Injectors Health Network (QuIHN), Treatment and Management Programme, 1 Hamilton Pl, Bowen Hills, Brisbane, QLD 4006, Australia., Martins A; Hospital Prof. Dr. Fernando Fonseca, IC19, 2720-276 Amadora, Portugal., Borgia SM; Infectious Diseases, William Osler Health System, 2100 Bovaird Dr E, Brampton, ON L6R 3J7, Canada., Vanstraelen K; Gilead Sciences Europe Ltd., Stockley Park, 2 Roundwood Ave, Hayes, Uxbridge UB11 1AS, UK., Mertens M; Gilead Sciences Europe Ltd., Stockley Park, 2 Roundwood Ave, Hayes, Uxbridge UB11 1AS, UK., Hernández C; Gilead Sciences Europe Ltd., Stockley Park, 2 Roundwood Ave, Hayes, Uxbridge UB11 1AS, UK., Ntalla I; Gilead Sciences Europe Ltd., Stockley Park, 2 Roundwood Ave, Hayes, Uxbridge UB11 1AS, UK., Ramroth H; Gilead Sciences Europe Ltd., Stockley Park, 2 Roundwood Ave, Hayes, Uxbridge UB11 1AS, UK., Milligan S; Trio Health Analytics, 1025 Cannon Street, Suite 2C, Louisville, CO 80027, USA.
Source: Viruses [Viruses] 2022 Nov 11; Vol. 14 (11). Date of Electronic Publication: 2022 Nov 11.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915 (Electronic) Linking ISSN: 19994915 NLM ISO Abbreviation: Viruses Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1999-4915
DOI:10.3390/v14112493